Publications by authors named "Sun Yansha"

Claim this Profile
E
Eugenol as a game-changer: overcoming osimertinib resistance in non-small cell lung cancer by inhibiting glycolysis via the tripartite motif containing 59/extracellular signal-regulated kinase pathway.
Kun Zhao, Wei Wang, Yansha Sun, Ke Li

Anticancer Drugs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center.
Shaohua Ge, Feixue Wang, Hongli Li, Yuchong Yang, Le Zhang, Yansha Sun

BMC Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer.
Shuning Xu, Danyang Li, Tao Ning, Yao Lu, Yansha Sun

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial.
Rui Liu, Zhi Ji, Xia Wang, Lila Zhu, Jiaqi Xin, Yansha Sun

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer.
Sun Ruixin, Liu Yifan, Sun Yansha, Zhou Min, Dong Yiwei

Br J Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma.
Rui-Xin Sun, Yi-Fan Liu, Yan-Sha Sun, Min Zhou, Yi Wang

Acta Pharmacol Sin· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.
Ting Deng, Feixue Wang, Le Zhang, Tao Ning, Yansha Sun

Cancer Immunol Immunother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
Jingjing Duan, Lila Zhu, Yinghui Shi, Weixue Wang, Tongtong Wang, Yansha Sun

BMC Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
Yuchong Yang, Hui Tan, Yao Lu, Jipeng Mei, Mengqi Zhang, Yansha Sun

BMC Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer.
Ruixin Sun, Yansha Sun, Chuanlong Wu, Yifan Liu, Min Zhou

Mol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer" biochemical pharmacology 212 (2023) 115536. PMID:37028461.
Sun Ruixin, Liu Yifan, Wu Chuanlong, Zhou Min, Luo Hong, Sun Yansha

Biochem Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer.
Sun Ruixin, Liu Yifan, Wu Chuanlong, Zhou Min, Luo Hong, Sun Yansha

Biochem Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.
Yuchong Yang, Yao Lu, Hui Tan, Ming Bai, Xia Wang, Yansha Sun

BMC Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.
Yifan Liu, Yansha Sun, Peng Wang, Songling Li, Yiwei Dong

J Transl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death.
Yi Wang, Honghong Zhang, Guoxiu Du, Hong Luo, Jingwen Su, Yansha Sun

Mol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors.
Yansha Sun, Yiwei Dong, Ruixin Sun, Yifan Liu, Yi Wang

Mol Ther Oncolytics· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review.
Yansha Sun, Wanhua Chang, Juan Yao, Haiyan Liu, Xiaofei Zhang

J Int Med Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice.
Ruixin Sun, Hong Luo, Jingwen Su, Shengmeng Di, Min Zhou, Yansha Sun

Mol Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment.
Yi Wang, Hua Jiang, Hong Luo, Yansha Sun, Bizhi Shi

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion.
Hong Luo, Jingwen Su, Ruixin Sun, Yansha Sun, Yi Wang

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells.
Hong Luo, Xiuqi Wu, Ruixin Sun, Jingwen Su, Yi Wang, Yansha Sun

Front Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice.
Muhua Chen, Ruixin Sun, Bizhi Shi, Yi Wang, Shengmeng Di, Yansha Sun

Biomed Pharmacother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The role of the retinoid-related orphan receptor α in the regulation of lipid metabolism].
Jia-Chen Lin, Yan-Sha Sun, Bo-Ya Zhou

Sheng Li Ke Xue Jin Zhan· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis